A Hyderabad paediatrician faces a legal notice from pharmaceutical firms for allegedly making “false and defamatory” remarks on social media about their products. The doctor raised concerns about the rebranding of ORSL to ERZL, citing potential consumer confusion and the presence of sucralose, which she believes should not be a daily consumption item for children.
